EBOS Group Limited announced the appointment of Julie Tay as an independent director, effective 15 May 2023. Ms. Tay joins EBOS with over 30 years' experience in international executive and non-executive roles across consumer healthcare, medical devices and digital healthcare. Ms. Tay is currently a director of Sonova Holdings, a global hearing care solutions company, headquartered in Switzerland and listed on the Swiss stock exchange.

During her executive career, Ms. Tay was most recently Senior Vice President and Managing Director, Asia Pacific for Align Technology, which is a global medical device company focused on the orthodontic and dental markets. In this role she launched Align Technology in Asia and, over nine years, established the company's primary product, Invisalign, as a leading brand across 14 markets. During this time, Ms. Tay was also a member of the global Executive Management Committee for Align Technology.

Prior to this time, Ms. Tay was regional head of Bayer Healthcare (Diabetes Care) in Asia Pacific and also previously held senior executive roles in Asia at Johnson Diversey and Johnson & Johnson. Ms. Tay holds a Bachelor of Psychology and Political Science from the National University of Singapore and an MBA from Curtin University of Technology in Perth. Ms. Tay has also completed the International Directors Program at INSEAD.

Ms. Tay resides in Singapore.